- Home
- GH vs SEM Comparison
GH vs SEM Comparison
Compare GH & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- SEM
- Stock Information
- Founded
- GH 2011
- SEM 1996
- Country
- GH United States
- SEM United States
- Employees
- GH N/A
- SEM N/A
- Industry
- GH Medical Specialities
- SEM Hospital/Nursing Management
- Sector
- GH Health Care
- SEM Health Care
- Exchange
- GH Nasdaq
- SEM Nasdaq
- Market Cap
- GH 4.9B
- SEM 1.9B
- IPO Year
- GH 2018
- SEM 2009
- Fundamental
- Price
- GH $50.15
- SEM $14.74
- Analyst Decision
- GH Strong Buy
- SEM Buy
- Analyst Count
- GH 20
- SEM 4
- Target Price
- GH $54.35
- SEM $27.33
- AVG Volume (30 Days)
- GH 2.0M
- SEM 1.3M
- Earning Date
- GH 08-06-2025
- SEM 07-31-2025
- Dividend Yield
- GH N/A
- SEM 1.71%
- EPS Growth
- GH N/A
- SEM N/A
- EPS
- GH N/A
- SEM 1.37
- Revenue
- GH $773,996,000.00
- SEM $5,219,066,000.00
- Revenue This Year
- GH $23.14
- SEM $5.26
- Revenue Next Year
- GH $21.42
- SEM $5.48
- P/E Ratio
- GH N/A
- SEM $30.10
- Revenue Growth
- GH 28.20
- SEM 16.44
- 52 Week Low
- GH $20.14
- SEM $14.03
- 52 Week High
- GH $53.42
- SEM $40.98
- Technical
- Relative Strength Index (RSI)
- GH 56.81
- SEM 43.43
- Support Level
- GH $48.90
- SEM $14.39
- Resistance Level
- GH $52.46
- SEM $15.26
- Average True Range (ATR)
- GH 1.97
- SEM 0.37
- MACD
- GH -0.23
- SEM -0.03
- Stochastic Oscillator
- GH 48.74
- SEM 31.94
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.